Chemed Analyst Ratings
Chemed Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/31/2023 | 10.44% | RBC Capital | $610 → $576 | Maintains | Outperform |
| 07/27/2023 | 13.12% | Oppenheimer | $610 → $590 | Maintains | Outperform |
| 05/01/2023 | 16.96% | RBC Capital | $587 → $610 | Maintains | Outperform |
| 04/28/2023 | 16.96% | Oppenheimer | $580 → $610 | Maintains | Outperform |
| 02/27/2023 | 12.55% | RBC Capital | $545 → $587 | Maintains | Outperform |
| 11/03/2022 | 4.5% | RBC Capital | $541 → $545 | Maintains | Outperform |
| 08/01/2022 | 3.73% | RBC Capital | $592 → $541 | Maintains | Outperform |
| 04/28/2022 | 13.51% | RBC Capital | $579 → $592 | Maintains | Outperform |
| 03/04/2022 | 11.02% | RBC Capital | $609 → $579 | Maintains | Outperform |
| 07/29/2021 | 16.77% | RBC Capital | $604 → $609 | Maintains | Outperform |
| 02/25/2021 | 11.21% | Oppenheimer | $600 → $580 | Maintains | Outperform |
| 03/11/2020 | 2.58% | RBC Capital | $448 → $535 | Upgrades | Sector Perform → Outperform |
| 02/19/2020 | 2.58% | Oppenheimer | $525 → $535 | Maintains | Outperform |
| 11/25/2019 | -9.88% | Oppenheimer | $440 → $470 | Maintains | Perform |
| 11/01/2019 | -6.05% | JMP Securities | → $490 | Upgrades | Market Perform → Market Outperform |
| 02/25/2019 | -39.03% | RBC Capital | $313 → $318 | Maintains | Sector Perform |
| 10/12/2018 | -25.22% | B of A Securities | → $390 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 07/31/2023 | 10.44% | 加拿大皇家银行资本 | $610→$576 | 维护 | 跑赢大盘 |
| 07/27/2023 | 13.12% | 奥本海默 | $610→$590 | 维护 | 跑赢大盘 |
| 05/01/2023 | 16.96% | 加拿大皇家银行资本 | $587→$610 | 维护 | 跑赢大盘 |
| 04/28/2023 | 16.96% | 奥本海默 | $580→$610 | 维护 | 跑赢大盘 |
| 02/27/2023 | 12.55% | 加拿大皇家银行资本 | $545→$587 | 维护 | 跑赢大盘 |
| 11/03/2022 | 4.5% | 加拿大皇家银行资本 | $541→$545 | 维护 | 跑赢大盘 |
| 08/01/2022 | 3.73% | 加拿大皇家银行资本 | $592→$541 | 维护 | 跑赢大盘 |
| 04/28/2022 | 13.51% | 加拿大皇家银行资本 | $579→$592 | 维护 | 跑赢大盘 |
| 03/04/2022 | 11.02% | 加拿大皇家银行资本 | $609→$579 | 维护 | 跑赢大盘 |
| 07/29/2021 | 16.77% | 加拿大皇家银行资本 | $604→$609 | 维护 | 跑赢大盘 |
| 02/25/2021 | 11.21% | 奥本海默 | $600→$580 | 维护 | 跑赢大盘 |
| 03/11/2020 | 2.58% | 加拿大皇家银行资本 | $448→$535 | 升级 | 行业表现优于→ |
| 02/19/2020 | 2.58% | 奥本海默 | $525→$535 | 维护 | 跑赢大盘 |
| 2019年11月25日 | -9.88% | 奥本海默 | $440→$470 | 维护 | 执行 |
| 2019/11/01 | -6.05% | JMP证券 | →$490 | 升级 | 市场表现优于→市场表现 |
| 2019年02月25日 | -39.03% | 加拿大皇家银行资本 | $313→$318 | 维护 | 行业表现 |
| 2018年10月12日 | -25.22% | B of A证券 | →$390 | 开始承保 | →购买 |
What is the target price for Chemed (CHE)?
中国化工的目标价格是多少？
The latest price target for Chemed (NYSE: CHE) was reported by RBC Capital on July 31, 2023. The analyst firm set a price target for $576.00 expecting CHE to rise to within 12 months (a possible 10.44% upside). 7 analyst firms have reported ratings in the last year.
加拿大皇家银行资本公司于2023年7月31日报道了中国化工(纽约证券交易所代码：CHE)的最新目标价。这家分析公司将目标价定为576.00美元，预计CHE将在12个月内上涨(涨幅可能为10.44%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Chemed (CHE)?
分析师对中国化工的最新评级是多少？
The latest analyst rating for Chemed (NYSE: CHE) was provided by RBC Capital, and Chemed maintained their outperform rating.
加拿大皇家银行资本对中国化工(纽约证券交易所股票代码：CHE)的最新分析师评级是由加拿大皇家银行资本提供的，中国化工维持其表现优于大盘的评级。
When is the next analyst rating going to be posted or updated for Chemed (CHE)?
中国化工(CHE)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chemed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chemed was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与CHIME的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。中国化工的上一次评级是在2023年7月31日提交的，所以你应该预计下一次评级将在2024年7月31日左右提供。
Is the Analyst Rating Chemed (CHE) correct?
分析师评级中国(CHE)正确吗？
While ratings are subjective and will change, the latest Chemed (CHE) rating was a maintained with a price target of $610.00 to $576.00. The current price Chemed (CHE) is trading at is $521.55, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的中国化工(CHE)评级维持不变，目标价在610.00美元至576.00美元之间。中国化工目前的交易价格为521.55美元，超出了分析师的预测范围。